Episode Details

Back to Episodes

The heavy impact of weight loss drugs

Published 2 years, 3 months ago
Description

Weight loss drugs that aim to radically curb appetites and prevent a host of obesity-related health problems are seeing unprecedented demand. At the same time, these drugs — sold under the brand names Ozempic, Wegovy and Zepbound — are raising questions for the food industry and companies that rely on cravings to sell their products. Capital Group portfolio manager Carl Kawaja shares his view on the heavy impact of weight loss drugs. #CapGroupGlobal

 



For full disclosures go to
capitalgroup.com/global-disclosures

 




For our latest insights, practice management ideas and more, subscribe to Capital Ideas at
getcapitalideas.com. If you're based outside of the U.S., visit capitalgroup.com for Capital Group in

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us